MAKEDA BERHANE: Open Payments
NPI 1730834722 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 35 payments from 13 companies in 2025. Trend: 2023 $813 · 2024 $899 · 2025 $1,603
Food & beverage: $1,519Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $339 |
| ABBVIE INC. | 7 | $283 |
| Madrigal Pharmaceuticals | 4 | $224 |
| Regeneron Healthcare Solutions, Inc. | 7 | $212 |
| Ardelyx, Inc. | 1 | $122 |
| Intercept Pharmaceuticals, Inc. | 1 | $111 |
| PFIZER INC. | 1 | $102 |
| QOL Medical, LLC | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $53 |
| Exact Sciences Corporation | 2 | $42 |
Products named: TREMFYA, REZDIFFRA, LINZESS, DUPIXENT, IBSRELA, OCALIVA, VELSIPITY, Sucraid.
Industry payments across MD — which companies pay providers there.
